跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,692 条关于
“Gastroesophageal adenocarcinoma”
全部
6,692
临床试验
5,841
药物
26
机构
1
资讯
824
去年
Keytruda/Lenvima Combo Shows Mixed Results in Gastroesophageal Adenocarcinoma Trial
10个月前
Zymeworks Pivots to Royalty-Driven Model Following Ziihera's Late-Stage Success in Gastroesophageal Cancer
10个月前
Ziihera Demonstrates Superior Efficacy in Phase 3 Trial for HER2-Positive Gastroesophageal Cancer
去年
FLOT Regimen Emerges as Superior Treatment for Localized Gastroesophageal Cancer, Outperforming Radiation Therapy
上个月
Esophageal Cancer Market Poised for 6% CAGR Growth Through 2036, Driven by ADC and Immunotherapy Innovation
2年前
Zanidatamab Shows Promise in HER2-Positive Gastroesophageal and Colorectal Cancers
2年前
Domvanalimab Combination Shows Promise in First-Line Gastroesophageal Cancer Treatment
去年
Merck and Eisai's Keytruda-Lenvima Combo Shows Mixed Phase 3 Results in Gastric Cancer
去年
Novel Triple Immunotherapy Combination Shows Promise in PD-1 Resistant Gastroesophageal Cancer
8个月前
Jazz Pharmaceuticals Reports Record $4.3 Billion Revenue in 2025, Prepares Zanidatamab Launch for Gastroesophageal Cancer
第 1 页，共 83 页
上一页
下一页
